A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BPA / boronophenylalanine

[Related PubMed/MEDLINE]
Total Number of Papers: 223
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BPA  (>> Co-occurring Abbreviation)
Long Form:   boronophenylalanine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter. BNCT
2019 Design and synthesis of novel organometallic complexes using boronated phenylalanine derivatives as potential anticancer agents. HUVECs
2019 Effect of a change in reactor power on response of murine solid tumors in vivo, referring to impact on quiescent tumor cell population. BrdU
2019 Folate receptor-targeted novel boron compound for boron neutron capture therapy on F98 glioma-bearing rats. BNCT, CED, FA, FR, i.v, MST, PBC
2019 Proposal for determining absolute biological effectiveness of boron neutron capture therapy-the effect of 10B(n,alpha)7Li dose can be predicted from the nucleocytoplasmic ratio or the cell size. ABE, BNCT
2018 A realistic appraisal of boron neutron capture therapy as a cancer treatment modality. BNCT
2018 Boron delivery agents for neutron capture therapy of cancer. BNCT
2018 Non-invasive estimation of 10 B-4-borono-L-phenylalanine-derived boron concentration in tumors by PET using 4-borono-2-18 F-fluoro-phenylalanine. 14 C-BPA, BNCT
2017 Practical calculation method to estimate the absolute boron concentration in tissues using 18F-FBPA PET. eBC, ICP-OES, mBC, SUVs
10  2016 A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma. BNCT
11  2016 An analysis of the structureof the compound biological effectiveness factor. CBE, el-CBE, GBF, il-CBE, N/B, nv-CBE, v-CBE
12  2016 An improved neutron autoradiography set-up for (10)B concentration measurements in biological samples. BNCT
13  2016 Boron neutron capture synovectomy (BNCS) as a potential therapy for rheumatoid arthritis: radiobiological studies at RA-1 Nuclear Reactor in a model of antigen-induced arthritis in rabbits. AIA, BNCS, MRI
14  2016 Detection of Protein-Protein Interaction Within an RNA-Protein Complex Via Unnatural-Amino-Acid-Mediated Photochemical Crosslinking. ---
15  2016 DNA damage induced by boron neutron capture therapy is partially repaired by DNA ligase IV. BNCT, DSBs, LET
16  2015 Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines. BNCT, CBE, RBE, SF
17  2015 Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2. ---
18  2015 Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors. CTA, i.c, TK1
19  2015 Experimental Studies of Boronophenylalanine ((10)BPA) Biodistribution for the Individual Application of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma Treatment. BNCT
20  2015 Influence of p53 status on the effects of boron neutron capture therapy in glioblastoma. BNCT, KUR
21  2015 Proteomic analysis of cellular response induced by boron neutron capture reaction in human squamous cell carcinoma SAS cells. BNCR, LRMP
22  2015 Site-Specific Antibody Labeling by Covalent Photoconjugation of Z Domains Functionalized for Alkyne-Azide Cycloaddition Reactions. IgG
23  2015 Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy. BNCT, CED, i.v, PDT, TPFC
24  2015 Tetrakis(p-Carboranylthio-Tetrafluorophenyl)Chlorin (TPFC): Application for Photodynamic Therapy and Boron Neutron Capture Therapy. BNCT, CED, i.v, PDT, TPFC
25  2015 The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model. BNCT, IHC, PCa
26  2014 Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases. BNCT
27  2014 Boron neutron capture synovectomy (BNCS) as a potential therapy for rheumatoid arthritis: boron biodistribution study in a model of antigen-induced arthritis in rabbits. AIA, BNCS, IA, RA
28  2014 Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer. BNCT, OS
29  2014 Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas. ABCHC, ABCPC, i.p, ICP-OES, SIMS, UNAAs
30  2014 Facile method for the site-specific, covalent attachment of full-length IgG onto nanoparticles. EPL
31  2014 Optimization of photoactive protein Z for fast and efficient site-specific conjugation of native IgG. ---
32  2014 Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS). BNCT, SIMS
33  2014 Site-specific photoconjugation of antibodies using chemically synthesized IgG-binding domains. BBa, SPA
34  2014 Structure of the RNA polymerase assembly factor Crl and identification of its interaction surface with sigma S. RNAP
35  2013 Boron neutron capture therapy for oral precancer: proof of principle in an experimental animal model. BNCT
36  2013 Effect of bevacizumab treatment on p-boronophenylalanine distribution in murine tumor. BNCT, PGA
37  2013 Improved pharmaceutical stability of a boronphenylalanine mannitol formulation for boron neutron capture therapy. BNCT
38  2013 Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells. BNCT
39  2013 Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas. BNCT, SCC
40  2012 Boron neutron capture in prostate cancer cells. METNB, RBE
41  2012 Boron neutron capture therapy for glioblastoma multiforme: enhanced drug delivery and antitumor effect following blood-brain barrier disruption induced by focused ultrasound. FUS
42  2012 Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model. BC, BNCT, FBPA-Fr, PET
43  2012 Physicochemical investigation of the influence of saccharide-based parenteral formulation excipients on L-p-boronphenylalanine solubilisation for boron neutron capture therapy. HPCD, NMR
44  2012 Selective uptake of boronophenylalanine by glioma stem/progenitor cells. BNCT
45  2012 Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer. BNCT, Th- BPA-BNCT
46  2011 "Sequential" boron neutron capture therapy (BNCT): a novel approach to BNCT for the treatment of oral cancer in the hamster cheek pouch model. BNCT, Seq-BNCT
47  2011 Application of a novel boronated porphyrin (H₂OCP) as a dual sensitizer for both PDT and BNCT. BNCT, PDT
48  2011 Artificial neural networks to evaluate the boron concentration decreasing profile in blood-BPA samples of BNCT patients. ---
49  2011 Boron neutron capture therapy (BNCT) for the treatment of liver metastases: biodistribution studies of boron compounds in an experimental model. BNCT
50  2011 Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours. ---
51  2011 Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy. ABCPC, SIMS
52  2011 BPA uptake does not correlate with LAT1 and Ki67 expressions in tumor samples (results of EORTC trial 11001). ---
53  2011 Comparison of intracerebral delivery of carboplatin and photon irradiation with an optimized regimen for boron neutron capture therapy of the F98 rat glioma. BBBD, BNCT, CED, MST
54  2011 Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors. BNCT, CED, i.c, i.v, MIT, MST
55  2011 Evaluation of BPA uptake in clear cell sarcoma (CCS) in vitro and development of an in vivo model of CCS for BNCT studies. BNCT, CCS
56  2011 In vitro studies on stability of L-p-boronophenylalanine-fructose complex (BPA-F). BNCT, BPA-f
57  2011 Induction of multinucleation in oral squamous cell carcinoma tissue with mutated p53 surviving boron neutron capture therapy. BNCT, cdc2, SCC
58  2011 The TFIIF-like Rpc37/53 dimer lies at the center of a protein network to connect TFIIIC, Bdp1, and the RNA polymerase III active center. PIC, Pol III
59  2009 A simple and rapid method for measurement of (10)B-para-boronophenylalanine in the blood for boron neutron capture therapy using fluorescence spectrophotometry. BNCT, ICP
60  2009 Acquisition-weighted MRSI for detection and quantification of BNCT 10B-carrier L-p-boronophenylalanine-fructose complex, a phantom study. ---
61  2009 Biological evaluation of boronated unnatural amino acids as new boron carriers. ABCPC, BNCT, SIMS
62  2009 BNCT for skin melanoma in extremities: updated Argentine clinical results. CNEA, IOAHR
63  2009 Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT. BNCT
64  2009 Boron neutron capture therapy at the crossroads: challenges and opportunities. BNCT
65  2009 Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents. CED, EGFR, i.c, i.t, mAbs, PAMAM
66  2009 Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading. HPLC, RDS
67  2009 Calculations of dose distributions in the lungs of a rat model irradiated in the thermal column of the TRIGA reactor in Pavia. BNCT
68  2009 Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy. BNCT, LCOB
69  2009 Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors. BD, BD-EGF, BNCT, CED, i.c, i.t
70  2009 EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trial. BNCT, SCCHN
71  2009 Feasibility of boron neutron capture therapy for malignant spinal tumors. JCDS, RBE, T/N
72  2009 Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model. BNCT
73  2009 L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. LAT1, PCNA
74  2009 Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinoma. BNCT, SCC
75  2009 Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy. BNCT
76  2009 Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA. BA, BNCT
77  2009 Synthesis and evaluation of a novel liposome containing BPA-peptide conjugate for BNCT. BNCT
78  2009 T2 corrected quantification method of L-p-boronophenylalanine using proton magnetic resonance spectroscopy for boron neutron capture therapy. BNCT, MRS, NAA
79  2008 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy. BNCT, MRI
80  2008 An international dosimetry exchange for BNCT part II: computational dosimetry normalizations. BNCT, BNL, BSH, MIT
81  2008 Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). BNCT, BPA-f, GBM
82  2008 Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008). BNCT
83  2008 Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells. BNCT, MTT, Rb, SCC
84  2008 In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT). BNCT
85  2008 Neutron autoradiography imaging of selective boron uptake in human metastatic tumours. BNCT
86  2008 Site-specific cross-linking of TBP in vivo and in vitro reveals a direct functional interaction with the SAGA subunit Spt3. TBP
87  2008 Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors. 3CTA, BNCT, i.c, i.t, MIT, MSTs, TK
88  2008 Uptake of two 10B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001). BNCT, BSH, PGRS
89  2007 Assessment of chemical purity of 10B-enriched p-boronophenylalanine by high-performance liquid chromatography coupled on-line with inductively coupled plasma optical emission spectrometry. ---
90  2007 Boron neutron capture therapy for malignant tumors related to meningiomas. BNCT
91  2007 Boron neutron capture therapy in cancer: past, present and future. BNCT, LET, UTC
92  2007 Early effects of boron neutron capture therapy on rat glioma models. BNCT
93  2007 Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases. BNCT
94  2007 Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab. BNCT, CED, EGFR, i.t, mAb, MST
95  2007 Neuropathological postmortem evaluation of BNCT for GBM. BNCT, GBM
96  2007 Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer. BNCT, BW, NA, UTC
97  2007 Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model. BNCT
98  2007 Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET. BNCT, NF2, SUVs
99  2006 Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model. BNCT, BrdU, SCC, vWF
100  2006 First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET. BNCT